Saito Mitsuru, Kida Yoshikuni, Marumo Keishi
Department of Orthopaedic Surgery, Jikei University School of Medicine, Japan.
Clin Calcium. 2014 Jul;24(7):27-35.
It has become clear that a reduction in sex hormones from middle age onwards, increasing age, and an increase in oxidative stress related to lifestyle-related diseases can also reduce bone material properties in terms of collagen post-translational modification, crosslink formation. These changes lead to both qualitative and quantitative abnormalities in collagen, which is the major bone matrix protein. The intermolecular cross-link formation of collagen, which regulates bone-material attributes, is a mechanism independent of bone remodeling. In other words, cross-link formation is controlled by the environment surrounding the bone matrix, comprising cellular functions, oxidative stress, and glycation level. Because oxidative stress is also risk factor of arteriosclerosis and cardiovascular event, there is link between low bone quality and arteriosclerosis. High levels of pentosidine in urine or blood, or mild hyperhomocysteinemia which suggest bone collagen abnormalities, might be used as surrogate markers for evaluating bone quality, assessing the risk of bone fracture. Patients with osteoporosis can be divided into 3 types on the basis of bone density and with bone quality. We are entering an age in which the treatment of osteoporosis will be personalized, with drugs administered depending on these types.
很明显,从中年开始性激素减少、年龄增长以及与生活方式相关疾病有关的氧化应激增加,也会在胶原蛋白翻译后修饰、交联形成方面降低骨材料特性。这些变化导致作为主要骨基质蛋白的胶原蛋白出现质和量的异常。调节骨材料属性的胶原蛋白分子间交联形成是一种独立于骨重塑的机制。换句话说,交联形成受骨基质周围环境控制,包括细胞功能、氧化应激和糖基化水平。由于氧化应激也是动脉硬化和心血管事件的危险因素,因此低骨质量与动脉硬化之间存在联系。尿液或血液中高水平的戊糖苷或提示骨胶原蛋白异常的轻度高同型半胱氨酸血症,可能用作评估骨质量、评估骨折风险的替代标志物。骨质疏松症患者可根据骨密度和骨质量分为3种类型。我们正进入一个骨质疏松症治疗将个性化的时代,根据这些类型给药。